TRACEY E LINDEMAN

Allopathic & Osteopathic Physicians|Internal Medicine GALVESTON, TX NPI 1154765865

General Payments — all program years on this page

$1,855.33

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 96
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $426.83 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $426.8320

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
PFIZER INC. $108.604
Lilly USA, LLC $65.564
Astellas Pharma US Inc $59.272
Acerta Pharma LLC $49.853
Exact Sciences Corporation $39.172
DEXCOM, INC. $24.361
ABBVIE INC. $22.481
Merck Sharp & Dohme Corporation $22.101
Amgen Inc. $20.771
GlaxoSmithKline, LLC. $14.671

By program year

Program yearAmountRecords
2019 $211.896
2020 $488.8527
2021 $671.3040
2022 $33.852
2023 $22.611
2024 $426.8320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104389557 AstraZeneca Pharmaceuticals LP $18.56 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104885607 ABBVIE INC. $22.48 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105440924 AstraZeneca Pharmaceuticals LP $16.05 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105590026 AstraZeneca Pharmaceuticals LP $15.24 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114758701 Exact Sciences Corporation $25.83 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114758707 Exact Sciences Corporation $13.34 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115874784 Amgen Inc. $20.77 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116520922 GlaxoSmithKline, LLC. $14.67 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131178723 PFIZER INC. $29.50 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131379988 PFIZER INC. $31.02 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131872891 PFIZER INC. $21.84 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132086568 PFIZER INC. $26.24 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135467567 Lilly USA, LLC $13.16 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135469885 Lilly USA, LLC $13.87 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135469887 Lilly USA, LLC $16.79 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135483773 Lilly USA, LLC $21.74 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139323206 Astellas Pharma US Inc $32.25 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139340024 Astellas Pharma US Inc $27.02 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141927177 Merck Sharp & Dohme LLC $22.10 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153341643 Dexcom, Inc. $24.36 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.